Drug-Coated Balloon Angioplasty and Debulking for the Treatment of Femoropopliteal In-Stent Restenosis: A Systematic Review and Meta-Analysis.
Published
July 01, 2020
Journal
BioMed research international
PICOID
5f2be865
DOI
Citations
7
Keywords
Copyright
Copyright © 2020 Zhu Tong et al.
Patients/Population/Participants
599 participants
Intervention
drug-coated balloon angioplasty (DCB)
Comparison
percutaneous transluminal angioplasty (PTA)
Outcome
rate of patency
Abstract
P
I
C
O
The purpose of this article was to compare the efficiency and safety of drug-coated balloon angioplasty (DCB) and atherectomy with percutaneous transluminal angioplasty (PTA) in patients with femoropopliteal in-stent restenosis (ISR). Pubmed, Embase, and the Cochrane Central Register of Controlled Trials (CENTRAL) (all up to March 2019) were searched systematically. Trial sequential analysis (TSA) was conducted. 5 studies with 599 participants were included. Compared with PTA, DCB significantly increased the rate of patency (6 months: RR 1.65, 95% CI 1.30 to 2.09,